Navigation Links
Nephros Reports Second Quarter 2014 Financial Results
Date:8/14/2014

ration products or chronic renal failure therapy products at competitive prices or profitably;
  • we may encounter problems with our suppliers, manufacturers and distributors;
  • we may encounter unanticipated internal control deficiencies or weaknesses or ineffective disclosure controls and procedures;
  • we may not obtain appropriate or necessary regulatory approvals to achieve our business plan;
  • products that appeared promising to us in research or clinical trials may not demonstrate anticipated efficacy, safety or cost savings in subsequent pre-clinical or clinical trials;
  • we may not be able to secure or enforce adequate legal protection, including patent protection, for our products; and
  • we may not be able to achieve sales growth in key geographic markets.
  • More detailed information about the company and the risk factors that may affect the realization of forward-looking statements, including the forward-looking statements in this press release, is set forth in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2013 and our other periodic reports filed with the SEC. We urge you to read those documents free of charge at the SEC's web site at www.sec.gov. We do not undertake to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law.


    '/>"/>
    SOURCE Nephros, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Nephros Appoints Daron Evans to Board of Directors
    2. Nephros Reports Third Quarter 2013 Financial Results and Completes Bridge Financing
    3. Nephros Reports Second Quarter 2013 Financial Results
    4. Nephros Announces Completion of Rights Offering
    5. Nephros Reports First Quarter 2013 Financial Results
    6. Nephros Announces Rights Offering and Temporary Reduction in Exercise Price for March 2011 Warrants
    7. Nephros Reports 2012 Fourth Quarter and Full Year Financial Results
    8. Nephros Completes Bridge Financing
    9. Nephros and Chem-Aqua Announce Distribution Agreement
    10. Nephros Reports Third Quarter 2012 Financial Results
    11. Nephros Reports Second Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2015)... , May 21, 2015  (MUSE Booth ... Electronic Health Record (EHR) is invaluable in any ... EHRs are now a requirement and mainstream in ... continuously into the EHR is gaining traction in ... William Holmes, RN, Site Project Manager & Clinical ...
    (Date:5/21/2015)... In praising today,s unanimous passage of ... House Energy and Commerce Committee, the Senior Care ... the unique challenges facing long-term care (LTC) pharmacy ... exempting Part D beneficiaries in skilled nursing facilities ... "lock-in" provision. The SCPC has made the case ...
    (Date:5/21/2015)... and SEATTLE , May 21, ... the development of robotics, sensors and medical devices, announced ... the company,s Chief Financial Officer and head of Corporate ... in corporate development, business development and finance roles, including ... and Pendrell Corporation.  Mr. Woo will be located in ...
    Breaking Medicine Technology:Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3SCPC Applauds Unanimous House Panel Passage of 21st Century Cures Bill Recognizing Unique Challenges Facing Long Term Care (LTC) Pharmacy Patients, Providers 2Sarcos Corp. Announces Preston Woo as CFO and Head of Corporate Development 2
    ... (Pink Sheets: SNDY ) is pleased to announce ... surgical instruments in order to better align its product offerings ... has focused its R & D efforts into the design ... to accommodate the continual advances in Laparoscopic surgical procedures including ...
    ... Ala., March 24, 2011 Qualitest Pharmaceuticals today announced that ... tablets (generic Demadex®) in 5 mg, 10 mg, ... for the treatment of edema associated with congestive heart failure, ... hypertension alone or in combination with other antihypertensive agents. ...
    Cached Medicine Technology:Solos Endoscopy, Inc. Strengthens Current Line of Laparoscopic Instruments 2Qualitest Receives FDA Approval for Toresmide Tablets (Generic Demadex®) 5 mg, 10 mg, 20 mg, 100 mg, for the Treatment of Edema Associated with Congestive Heart Failure, Renal Disease, or Hepatic Disease 2Qualitest Receives FDA Approval for Toresmide Tablets (Generic Demadex®) 5 mg, 10 mg, 20 mg, 100 mg, for the Treatment of Edema Associated with Congestive Heart Failure, Renal Disease, or Hepatic Disease 3
    (Date:5/22/2015)... 2015 ZH Healthcare ... announced today that Bill Lane, joins ZH’s Advisory ... of BlueEHS,a first of its kind, Freemium SaaS, ... Electronic Health Records (EHR) with an integrated practice ... comprehensive patient portal, and more. Combined with its ...
    (Date:5/22/2015)... May 22, 2015 Gateway Building Concepts ... renovations. The services the company specialize in include decks, ... basements, pool houses and much more. , The ... the owner of the company. It includes two geometrical ... design was thought out to be used with many ...
    (Date:5/22/2015)... 2015 A Phase 3 French ... Society of Clinical Oncology (ASCO)’s annual meeting at ... for those patients who received bevacizumab in addition ... Bevacizumab (Avastin® Genentech, Inc.) is an antibody that ... already routinely used to treat many other cancers, ...
    (Date:5/22/2015)... 22, 2015 Ticket Down is a reputable ... Rangers NHL Eastern Conference Finals Tickets . All seating ... otherwise in the ticket listing. , For the first ... the top of the Eastern Conference. One of the original ... of ups and downs over the years, but the excitement ...
    (Date:5/22/2015)... May 22, 2015 In April 2006, ... the past 9 years they have concentrated their focus ... States and Canada. Because of this growth and their ... corporate offices in Denver, Colorado, Cleveland, Ohio, Houston, Texas ... in opening new dental offices, dental start ups, orthodontic ...
    Breaking Medicine News(10 mins):Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
    ... medulloblastoma in children , SATURDAY, June 5 (HealthDay News) ... treatment for medulloblastoma -- the most common malignant brain ... to treat drug-resistant forms of the disease. , "Less ... Dr. Amar Gajjar, lead author of the study, which ...
    ... chemotherapy, new drug prolonged lives of some with advanced ... report they prolonged survival for some patients with advanced ... is currently only about six months. , One ... tumors in the majority of lung cancer patients with ...
    ... Great HealthWorks, makers and distributors ... the top of Mt. Everest. , ... June 5, 2010 -- The Great HealthWorks Team wishes to congratulate Jordan Romero for achieving history ... Jordan saw a mural in the hallway at school of Mt. McKinley that caught his attention. ...
    ... halted early because of supplement,s poor performance , SATURDAY, ... supplement selenium doesn,t reduce the likelihood of lung cancer ... Daniel D. Karp, a professor in the department of ... Texas M.D. Anderson Cancer Center, is scheduled to present ...
    ... ... and Faces iMake, among Father’s Day 2010 GreatDad Recommends Award and Mr. Dad Seal of ... San Francisco, ... activities this year are in for a real treat. Presented by Mr. Dad and GreatDad.com, ...
    ... ... drug rehabs and prisons , ... (PRWEB) June 5, 2010 -- President Narconon International, Clark Carr, just finished ... withdrawal and relapse prevention technology to Mexico. Accompanied by U.S. and Mexican volunteers, Carr ...
    Cached Medicine News:Health News:Targeted Therapy Shows Promise Against Deadly Brain Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 3Health News:Great Healthworks, Makers Omega XL, Congratulates Jordan Romero as The Youngest Person to Ever Reach The Top of Mt. Everest 2Health News:Don't Count on Selenium to Prevent Lung Cancer Recurrence 2Health News:Mr. Dad and GreatDad.com Salute Fathers and Families with This Spring's ‘Seal of Approval' Picks 2Health News:Mr. Dad and GreatDad.com Salute Fathers and Families with This Spring's ‘Seal of Approval' Picks 3Health News:Mr. Dad and GreatDad.com Salute Fathers and Families with This Spring's ‘Seal of Approval' Picks 4Health News:Narconon Campaigns to Help Mexico Reduce Drug-related Violence in Sonora and Michoacan 2
    BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
    VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
    BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
    ... contain a buffered sodium citrate ... a citrate concentration of 0.109 ... (3.8%). The mixing ratio is ... 9 parts blood. In addition ...
    Medicine Products: